Susan G Komen Breast Cancer is categorized under Foundation Educational Philanthropic Research in Lexington, KY and active since 1996.
Susan G Komen Breast Cancer was established in 1996, and today employs 1 to 4, earning Unknown per year. This is a Foundation Educational Philanthropic Research business, which does work in the B2B market, and is classified as a Foundation Educational Philanthropic Research, under code number by the NAICS.
If you are seeking more information, feel free to contact Jennifer Bricking at the company’s single location by writing to 1795 Alysheba Way, Suite 3104, Lexington, Kentucky KY 40509 or by phoning (859) 368-7133. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Susan G Komen Breast Cancer |
Contact Person: | Jennifer Bricking |
Address: | 1795 Alysheba Way, Suite 3104, Lexington, Kentucky 40509 |
Phone Number: | (859) 368-7133 |
Annual Revenue (USD): | Unknown |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Foundation Educational Philanthropic Research |
Share This Business: |
Susan G Komen Breast Cancer was started in 1996 to provide professional Foundation Educational Philanthropic Research under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jennifer Bricking for inquiries that concern Susan G Komen Breast Cancer by calling the company number (859) 368-7133, as your correspondence is most welcome. Additionally, the physical location of the single location of Susan G Komen Breast Cancer can be found at the coordinates 38.016518,-84.422386 as well as the street address 1795 Alysheba Way, Suite 3104 in Lexington, Kentucky 40509.
For its online presence, you may visit Susan G Komen Breast Cancer’s website at and engage with its social media outlets through on Twitter and on Facebook.